Regeneron Pharmaceuticals, Inc.
ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
Status:
Application
Type:
Utility
Filling date:
13 Aug 2020
Issue date:
6 Jan 2022